Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY Trial.

[1]  A. Natale,et al.  Composite Index Tagging for PVI in Paroxysmal AF: A Prospective, Multicenter Postapproval Study. , 2022, JACC. Clinical electrophysiology.

[2]  A. De Simone,et al.  In vivo biophysical characterization of very high power, short duration, temperature‐controlled lesions , 2021, Pacing and clinical electrophysiology : PACE.

[3]  K. Kuck,et al.  Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study , 2021, International journal of cardiology. Heart & vasculature.

[4]  K. Yokoyama,et al.  Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With High Power–Short Duration and Moderate Power–Moderate Duration: Effects of Thermal Latency and Contact Force on Lesion Formation , 2021, Circulation. Arrhythmia and electrophysiology.

[5]  S. Knecht,et al.  Biosense Webster's QDOT Micro™ radiofrequency ablation catheter. , 2021, Future cardiology.

[6]  S. Knecht,et al.  Performance and Safety of Temperature- and Flow-Controlled Radiofrequency Ablation in Ablation Index-Guided Pulmonary Vein Isolation. , 2021, JACC. Clinical electrophysiology.

[7]  S. Dukkipati,et al.  High‐power short‐duration ablation of atrial fibrillation: A contemporary review , 2021, Pacing and clinical electrophysiology : PACE.

[8]  H. Calkins,et al.  Radiofrequency ablation: technological trends, challenges, and opportunities. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  R. Kobza,et al.  Improved Procedural Efficiency of Atrial Fibrillation Ablation Using a Dedicated Ablation Protocol and Lean Management. , 2020, JACC. Clinical electrophysiology.

[10]  Paul C. Zei,et al.  Safety and Efficacy of Minimal- versus Zero-fluoroscopy Radiofrequency Catheter Ablation for Atrial Fibrillation: A Multicenter, Prospective Study , 2020, The Journal of innovations in cardiac rhythm management.

[11]  F. Sacher,et al.  Temperature and flow controlled ablation/very high-power short-duration ablation vs Conventional power-controlled ablation: Comparison of focal and linear lesion characteristics. , 2020, Heart rhythm.

[12]  D. Lakkireddy Temperature-Controlled Catheter Ablation for Paroxysmal Atrial Fibrillation: The QDOT-MICRO Workflow Study , 2020, Journal of Atrial Fibrillation.

[13]  S. Knecht,et al.  Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[15]  F. Marchlinski,et al.  Long-term safety and effectiveness of paroxysmal atrial fibrillation ablation using a porous tip contact force-sensing catheter from the SMART SF trial , 2020, Journal of interventional cardiac electrophysiology.

[16]  L. Macle,et al.  Atrial fibrillation ablation with a spring sensor-irrigated contact force-sensing catheter compared with other ablation catheters: systematic literature review and meta-analysis , 2019, BMJ Open.

[17]  P. Neužil,et al.  Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. , 2019, JACC. Clinical electrophysiology.

[18]  H. Nakagawa,et al.  High‐power and short‐duration ablation for pulmonary vein isolation: Safety, efficacy, and long‐term durability , 2018, Journal of cardiovascular electrophysiology.

[19]  E. Anter,et al.  High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. , 2018, JACC. Clinical electrophysiology.

[20]  H. Nakagawa,et al.  Evaluation of a Strategy Aiming to Enclose the Pulmonary Veins With Contiguous and Optimized Radiofrequency Lesions in Paroxysmal Atrial Fibrillation: A Pilot Study. , 2018, JACC. Clinical electrophysiology.

[21]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary , 2017, Journal of Interventional Cardiac Electrophysiology.

[22]  J. Kautzner,et al.  High-Resolution Mapping of Ventricular Scar: Evaluation of a Novel Integrated Multielectrode Mapping and Ablation Catheter. , 2017, JACC. Clinical electrophysiology.

[23]  Laura J. Bonnett,et al.  Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  Dhanunjaya R. Lakkireddy,et al.  Relationship Between Catheter Stability and 12-Month Success After Pulmonary Vein Isolation: A Subanalysis of the SMART-AF Trial. , 2016, JACC. Clinical electrophysiology.

[25]  Douglas L. Packer,et al.  Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. , 2014, Journal of the American College of Cardiology.

[26]  Paul J. Wang,et al.  Outcomes and complications of catheter ablation for atrial fibrillation in females. , 2010, Heart rhythm.

[27]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.